Trial Profile
Comparative Treatment of Intravitreal Bevacizumab and Triamcinolone Acetonide on Diabetic Macular Edema
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Triamcinolone
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Acronyms IVBITA
- 30 Apr 2011 New trial record